Recently, a periostin-neutralizing antibody, PN1-Ab, has been developed, and it attenuates tumor growth of the primary breast carcinoma in animal models.28 Studies in myeloma are highly anticipated. This evidence concerns the gene POSTN and plasma cell myeloma.